Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response | Blood Advances | American Society of Hematology
Ashpublications.org 123d 1 tweets
Key Points. CB-derived adoptive cell therapy is a feasible and efficacious therapeutic approach for patients with refractory AML.Treatment response depends on


Blood Advances 123d ago
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response
3